Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets

CHEN Hongmei; KANG Yanliang; LIU Li; YAO Wenbing; TIAN Hong

doi:10.11665/j.issn.1000-5048.20200313

Journal of China Pharmaceutical University > 2020 > 51(3): 349-356. > DOI: 10.11665/j.issn.1000-5048.20200313

CHEN Hongmei, KANG Yanliang, LIU Li, YAO Wenbing, TIAN Hong. Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets[J]. Journal of China Pharmaceutical University, 2020, 51(3): 349-356. DOI: 10.11665/j.issn.1000-5048.20200313

Citation:

PDF (6087 KB)

Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets

Funds: This study was supported by the National Natural Science Foundation of China (No. 81973222, No.81673343, No.91753112)

More Information

Received Date: March 22, 2020
Revised Date: May 07, 2020

Graphical Abstract

Abstract

Abstract

To compare the effects of endogenous 3-nitrotyrosine and non-natural 4-nitrophenylalanine in PD-L1 vaccine on the differentiation of T cell subsets, two immunogenic amino acids were introduced into the same site of PD-L1 vaccine. Two PD-L1 mutants with 3-nitrotyrosine and 4-nitrophenylalanine were obtained, respectively, using genetic code expansion technology. Mice were immunized with these two mutants, and their effects on the differentiation of T cell subsets in spleen were analyzed. The results of flow cytometry showed that the introduction of 4-nitrophenylalanine in PD-L1 vaccine could promote the polarization of Th1 cells while reducing the proportion of Treg cells; the introduction of 3-nitrotyrosine had no effect on the polarization of Th1 cells, while significantly increasing the proportion of Treg and Th17 cells. The introduction of both into PD-L1 vaccine could promote the response of CD8⁺ T cells in spleen, and the response of PD-L1 mutant containing 4-nitrophenylalanine was stronger. In summary, the non-natural 4-nitrophenylalanine is more suitable for the design of tumor vaccines as compared with endogenous 3-nitrotyrosine.
- PD-L1,
- vaccine,
- 3-nitrotyrosine,
- 4-nitrophenylalanine,
- T cell differentiation

FullText(HTML)

References (17)

References

[1]	. Proc Natl Acad Sci U S A， 2008， 105（32）： 11276-11280.
[2]	Grünewald J， Hunt GS， Dong L， et al. Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids［J］. Proc Natl Acad Sci U S A， 2009， 106（11）： 4337-4342.
[3]	Khan F， Siddiqui AA. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis， osteoarthritis and systemic lupus erythematosus［J］. Clin Chim Acta， 2006， 370（1/2）： 100-107.
[4]	Khan F， Ali R. Antibodies against nitric oxide damaged poly L-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus［J］. J Biochem Mol Biol， 2006， 39（2）： 189-196.
[5]	Thomson L， Christie J， Vadseth C， et al. Identification of immunoglobulins that recognize 3-nitrotyrosine in patients with acute lung injury after major trauma［J］. Am J Respir Cell Mol Biol， 2007， 36（2）： 152-157.
[6]	Ohmori H， Kanayama N. Immunogenicity of an inflammation-associated product， tyrosine nitrated self-proteins［J］. Autoimmun Rev， 2005， 4（4）： 224-229.
[7]	Hardy LL， Wick DA， Webb JR. Conversion of tyrosine to the inflammation-associated analog 3''''-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells［J］. J Immunol， 2008， 180（9）： 5956-5962.
[8]	He Y， Tian H， Dai X， et al. Immunogenicity of HER2 vaccine containing p-nitrophenylalanine［J］. J China Pharm Univ （中国药科大学学报）， 2018， 49（3）： 369-375.
[9]	Tian H， He Y， Song XD， et al. Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity［J］. Cancer Lett， 2018， 430： 79-87.
[10]	Tian H， Kang YL， Song XD， et al. PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses［J］. Cancer Lett， 2020， 476： 170-182.
[11]	Datta J， Fracol M， McMillan MT， et al. Association of depressed anti-HER2 T-helper type 1 response with recurrence in patients with completely treated HER2-positive breast cancer： role for immune monitoring［J］. JAMA Oncol， 2016， 2（2）： 242-246.
[12]	Antony PA， Piccirillo CA， Akpinarli A， et al. CD8⁺ T cell immunity against a tumor/self-antigen is augmented by CD4⁺ T helper cells and hindered by naturally occurring T regulatory cells［J］. J Immunol， 2005， 174（5）： 2591-2601.
[13]	Lakshminrusimha S， Suresh MV， Knight PR， et al. Role of pulmonary artery reactivity and nitric oxide in injury and inflammation following lung contusion［J］. Shock， 2013， 39（3）： 278-285.
[14]	Thomson L. 3-Nitrotyrosine modified proteins in atherosclerosis［J］. Dis Markers， 2015， 2015： 1-8.
[15]	Ferreira I， Croca S， Raimondo MG， et al. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus； a multi-center retrospective case-control study［J］. Arthritis Res Ther， 2017， 19（1）： 287.
[16]	Jin B， Sun T， Yu XH， et al. The effects of TLR activation on T-cell development and differentiation［J］. Clin Dev Immunol， 2012， 2012： 836485.
[17]	Li P， Spolski R， Liao W， et al. Complex interactions of transcription factors in mediating cytokine biology in T cells［J］. Immunol Rev， 2014， 261（1）： 141-156.

[1]	LI Hongxue, ZHANG Lei. Analysis of patent applications of heterocyclic compounds in China Pharmaceutical University 2010-2014[J]. Journal of China Pharmaceutical University, 2016, 47(2): 247-250. DOI: 10.11665/j.issn.1000-5048.20160220
[2]	MAO Dan. Patent analysis of pharmaceutical cocrystals technology in China[J]. Journal of China Pharmaceutical University, 2015, 46(4): 509-512. DOI: 10.11665/j.issn.1000-5048.20150421
[3]	WANG Jingjing, WANG Huiyan, ZHANG Lingling, XIAO Jing, HU Weiguo, ZHANG Caixia, ZHOU Jie. Technical analysis of low molecule weight heparins patents and R&D suggestions[J]. Journal of China Pharmaceutical University, 2015, 46(4): 504-508. DOI: 10.11665/j.issn.1000-5048.20150420
[4]	X-Ray Diffraction Fourier Fingerprint Pattern Analysis for Qingkailing Patent Medicine[J]. Journal of China Pharmaceutical University, 2004, (2): 41-43.
[5]	Study on Related Substances and Stability of Ceftazidime and its Preparation[J]. Journal of China Pharmaceutical University, 2002, (2): 35-38.
[6]	System Separation of Cyclosporin A Triple Therapeutic Drugs by Micellar Electrokinetic Capillary Chromatography and Evaluation of Optimal Method Ruggedness[J]. Journal of China Pharmaceutical University, 1999, (5): 373-376.
[7]	HPLC Analysis of Metoprolol and Its Metabolites in the Perfusates[J]. Journal of China Pharmaceutical University, 1997, (6): 31-35.
[8]	NMR Analysis of Bromocriptine Mesilate Tenoxicam[J]. Journal of China Pharmaceutical University, 1997, (5): 33-35.
[9]	Studies on the Synthesis and Analysis of Impurities and Decomposition Product of Ondansetron Hydrochlorid[J]. Journal of China Pharmaceutical University, 1997, (4): 8-10.
[10]	The Preparation and Analysis of New Sweetener L-Asp-D-Ala-OiPr[J]. Journal of China Pharmaceutical University, 1997, (2): 114-115.

Cited By

Get Citation

PDF

XML

Article views PDF downloads

Turn off MathJax

Article Contents

Abstract

References

Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets

Abstract

References

Related Articles

Catalog

Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content